PubMed Health⌕ Search

PubMed · 11190946

A statistical methodology for mammographic density detection.

Abstract

A statistical methodology is presented based on a chi-square probability analysis that allows the automated discrimination of radiolucent tissue (fat) from radiographic densities (fibroglandular tissue) in digitized mammograms. The method is based on earlier work developed at this facility that shows mammograms may be considered as evolving from a linear filtering operation where a random input field is passed through a 1/f filtering process. The filtering process is reversible which allows the solution of the input field with knowledge obtained from the raw image (the output). The input field solution is analogous to a prewhitening technique or deconvolution. This field contains all the information of the raw image in a much simplified format that can be approximated and analyzed with parametric methods. In the work presented here evidence indicates that there are two random events occurring in the input field with differing variances: (1) one relating to fat tissue with the smaller variance, and (2) the second relating to all other tissue with the larger variance. A statistical comparison of the variances is made by scanning the image with a small search window. A relaxation method allows for making a reliable estimate of the smaller variance which is considered as the global reference. If a local variance deviates significantly from the reference variance, based on chi-square analysis, it is labeled as nonfat; otherwise it is labeled as fat. This statistical test procedure results in a region by region continuous labeling of fat and nonfat tissue across the image. In the work presented here, the emphasis is on the methodology development with supporting preliminary results that are very encouraging. It is widely accepted that mammographic density is a breast cancer risk factor. An important application of this work is to incorporate density-based risk analysis into the ongoing statistical-based detection work developed at this facility. Additional applications include risk analysis dependent on either percentages or total amounts of fat or dense tissue. This work may be considered as the initial step in introducing many of the known breast cancer risk factors into the actual image data analysis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Heine, R P Velthuizen. 2000. A statistical methodology for mammographic density detection.. https://doi.org/10.1118/1.1323981

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer.

The transcription factor Forkhead-box A1 (Foxa1), a member of the FOX class of transcription factors, has been implicated in the pathogenesis of lung, esophageal and prostate cancers. We have recently identified transcriptional activation of p27 by FOXA1. In this study, we analyzed the activities and expression pattern of FOXA1 in breast cancer. Forced expression of FOXA1 inhibited clonal growth of breast cancer cell lines, and FOXA1 levels inversely correlated with growth stimuli. In the estrogen receptor (ER)-positive MCF-7 cells, FOXA1 increased p27 promoter activity and inhibited the ER pathway activity. Analysis of FOXA1 expression in breast tissue arrays revealed significantly higher expression in pure ductal carcinomas in situ compared to invasive ductal carcinomas (IDC); and in IDC, high expression of FOXA1 was associated with favorable prognostic factors. Yet, FOXA1 expression was noted in a subset of the ER-negative tumors. Taken together, our findings suggest a growth inhibitory role for FOXA1, and identify it as a novel, potential prognostic factor in breast cancer.

Breast↗

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

BACKGROUND: Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 (CD44+CD24-/low) that have higher tumorigenic capacity than other subtypes of cancer cells. METHODS: We compared the gene-expression profile of CD44+CD24-/low tumorigenic breast-cancer cells with that of normal breast epithelium. Differentially expressed genes were used to generate a 186-gene "invasiveness" gene signature (IGS), which was evaluated for its association with overall survival and metastasis-free survival in patients with breast cancer or other types of cancer. RESULTS: There was a significant association between the IGS and both overall and metastasis-free survival (P<0.001, for both) in patients with breast cancer, which was independent of established clinical and pathological variables. When combined with the prognostic criteria of the National Institutes of Health, the IGS was used to stratify patients with high-risk early breast cancer into prognostic categories (good or poor); among patients with a good prognosis, the 10-year rate of metastasis-free survival was 81%, and among those with a poor prognosis, it was 57%. The IGS was also associated with the prognosis in medulloblastoma (P=0.004), lung cancer (P=0.03), and prostate cancer (P=0.01). The prognostic power of the IGS was increased when combined with the wound-response (WR) signature. CONCLUSIONS: The IGS is strongly associated with metastasis-free survival and overall survival for four different types of tumors. This genetic signature of tumorigenic breast-cancer cells was even more strongly associated with clinical outcomes when combined with the WR signature in breast cancer.

Breast↗